Similar clinical responses achieved with lower versus standard doses of infliximab biosimilar CT-P13 in patients with ankylosing spondylitis: real world results from the RAAS study.
유대현
제목
Similar clinical responses achieved with lower versus standard doses of infliximab biosimilar CT-P13 in patients with ankylosing spondylitis: real world results from the RAAS study.